These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38474337)

  • 1. Allopurinol Disrupts Purine Metabolism to Increase Damage in Experimental Colitis.
    Worledge CS; Kostelecky RE; Zhou L; Bhagavatula G; Colgan SP; Lee JS
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine metabolism and inhibition of xanthine oxidase in severely hypoxic neonates going onto extracorporeal membrane oxygenation.
    Marro PJ; Baumgart S; Delivoria-Papadopoulos M; Zirin S; Corcoran L; McGaurn SP; Davis LE; Clancy RR
    Pediatr Res; 1997 Apr; 41(4 Pt 1):513-20. PubMed ID: 9098853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Torres RJ; Prior C; Puig JG
    Metabolism; 2007 Sep; 56(9):1179-86. PubMed ID: 17697859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfecting a high hypoxanthine phosphoribosyltransferase activity-uricase KO mice to test the effects of purine- and non-purine-type xanthine dehydrogenase (XDH) inhibitors.
    Hosoya T; Uchida S; Shibata S; Tomioka NH; Hosoyamada M
    Br J Pharmacol; 2020 May; 177(10):2274-2285. PubMed ID: 31971609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Inflammation as a Dysbiosis of Energy Procurement: New Insights into an Old Topic.
    Lee JS; Wang RX; Alexeev EE; Colgan SP
    Gut Microbes; 2021; 13(1):1-20. PubMed ID: 33583319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of excessive purine biosynthesis in hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Sorensen LB
    J Clin Invest; 1970 May; 49(5):968-78. PubMed ID: 5441549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxanthine is a checkpoint stress metabolite in colonic epithelial energy modulation and barrier function.
    Lee JS; Wang RX; Alexeev EE; Lanis JM; Battista KD; Glover LE; Colgan SP
    J Biol Chem; 2018 Apr; 293(16):6039-6051. PubMed ID: 29487135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nutritional state and allopurinol on purine metabolism in the rat small intestine.
    Gross CJ; Stiles JE; Savaiano DA
    Biochim Biophys Acta; 1988 Jul; 966(1):168-75. PubMed ID: 3390463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of allopurinol on beer-induced increases in plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine).
    Ka T; Moriwaki Y; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Yamamoto T
    Horm Metab Res; 2006 Mar; 38(3):188-92. PubMed ID: 16673211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on purine-pyrimidine metabolism (1)--Quantitation of purine-pyrimidine metabolites and allopurinol-oxipurinol in biological fluids].
    Hiroshige K; Kunifuji Y; Takasugi M; Kuroiwa A
    J UOEH; 1992 Sep; 14(3):211-8. PubMed ID: 1410939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Purine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase deficiency].
    López Jiménez M; García Puig J; Mateos Antón F; Ramos Hernández T; Pascual Castroviejo I; Ortiz Vázquez J
    Med Clin (Barc); 1989 Feb; 92(5):167-70. PubMed ID: 2725104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients.
    Torres RJ; Prior C; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1077-82. PubMed ID: 17065067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-mechanistic Modeling of Hypoxanthine, Xanthine, and Uric Acid Metabolism in Asphyxiated Neonates.
    Chu WY; Allegaert K; Dorlo TPC; Huitema ADR;
    Clin Pharmacokinet; 2022 Nov; 61(11):1545-1558. PubMed ID: 36040612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis.
    Wu J; Wei Z; Cheng P; Qian C; Xu F; Yang Y; Wang A; Chen W; Sun Z; Lu Y
    Theranostics; 2020; 10(23):10665-10679. PubMed ID: 32929373
    [No Abstract]   [Full Text] [Related]  

  • 15. Purine and carnitine metabolism in muscle of patients with Duchenne muscular dystrophy.
    Camiña F; Novo-Rodriguez MI; Rodriguez-Segade S; Castro-Gago M
    Clin Chim Acta; 1995 Dec; 243(2):151-64. PubMed ID: 8747491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting PNP for the therapy of hyperuricemia in Lesch-Nyhan disease: Preliminary in vitro studies with analogues of immucillin-G.
    Jacomelli G; Baldini E; Mugnaini C; Micheli V; Bernardini G; Santucci A
    J Inherit Metab Dis; 2019 Jan; 42(1):178-185. PubMed ID: 30740729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An insight into prototropism and supramolecular motifs in solid-state structures of allopurinol, hypoxanthine, xanthine, and uric acid. A ¹H-¹⁴N NQDR spectroscopy, hybrid DFT/QTAIM, and Hirshfeld surface-based study.
    Latosińska JN; Latosińska M; Seliger J; Žagar V; Kazimierczuk Z
    J Phys Chem B; 2014 Sep; 118(37):10837-53. PubMed ID: 25079386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine nucleoside transport and metabolism in isolated rat jejunum.
    Stow RA; Bronk JR
    J Physiol; 1993 Aug; 468():311-24. PubMed ID: 8254512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The conversion of 4-hydroxypyrazolo[3,4-d]pyrimidine (allopurinol) into 4,6-dihroxypyrazolo[3,4-d]pyrimidine (Oxipurinol) in vivo in the absence of xanthine-oxen oxidoreductase.
    Chalmers RA; Parker R; Simmonds HA; Snedden W; Watts RW
    Biochem J; 1969 May; 112(4):527-32. PubMed ID: 5801674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced purine salvage during allopurinol therapy: an important pharmacologic property in humans.
    Edwards NL; Recker D; Airozo D; Fox IH
    J Lab Clin Med; 1981 Nov; 98(5):673-83. PubMed ID: 7299239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.